Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn't want to find stocks that are either flying under the radar and are ...

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always ...

EpiPen pricing scandal has sent Mylan stock below $40 and to 52-week lows. Teva failed in its attempt to acquire Mylan last year. Mylan's reduced market capitalization could whet its appetite once ...

Mylan N.V. (NASDAQ:MYL) is doing well today, up 1.5% to trade at $40.97 after receiving an upgrade to "outperform" from "market perform" at Leerink. After starting 2018 off strong with an annual high ...

A new Mylan-Pfizer deal that will have the companies undergoing a merger has MYL stock on the rise Monday. The deal between Mylan (NASDAQ:MYL) and Pfizer (NYSE:PFE) will have the former combining with ...

Mylan NV shares dropped 1.9% in midday trade Tuesday after the Food and Drug Administration released a warning letter to the company about violations at a manufacturing facility in India. Until all ...

Going by the historical performance, we believe that the stock price of Mylan (NYSE: MYL), a pharmaceutical company best known for its generic drugs, could offer an upside of over 45% from the current ...

MYL stock was up as much as 13% in premarket trading. Mylan struck the deal last Friday after the market closed to pay the U.S. Department of Justice, as well as other agencies, over whether or not ...

Mylan NV (NASDAQ:MYL) is down 0.7%, last seen trading at $15.39, amid news that the pharmaceutical company named Chairman Robert Coury to be the new executive chairman, the second time Coury has been ...

Mylan, a company best known for generic drugs, watched its stock slide last year after it was named along with other generic-drug manufacturers in a case alleging price-fixing. The lawsuit, brought by ...